Who
Mathias Hukkelhoven
Director
Company insider
Files Form 4 as: Director, Compugen; Director, Centessa Pharmaceuticals.
In numbers
- Trades disclosed
- 16
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 1 Jul 2022
- Last trade
- 29 Jul 2026
- Last filed
- 30 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Jul 2026filed 30 Jul 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 29 Jul 2026filed 30 Jul 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 29 Jul 2026filed 30 Jul 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 29 Jul 2026filed 30 Jul 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —96,000 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —48,000 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —48,000 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —96,000 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —48,000 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —48,000 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —40,000 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —40,000 | filing |
| 20 Jun 2025filed 24 Jun 2025 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 25 Jun 2024filed 27 Jun 2024 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —48,000 at $0.00 | filing |
| 22 Jun 2023filed 23 Jun 2023 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —48,000 at $0.00 | filing |
| 1 Jul 2022filed 6 Jul 2022 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —96,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.